In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline – the first report from Croatia-Reference-Cited by-同舟云学术

In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline – the first report from Croatia

Published:2021-08-17 Issue:1 Volume:34 Page:67-70
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Jurić Ivana¹,Bošnjak Zrinka¹²,Ćorić Mario²³,Lešin Joško²³,Mareković Ivana¹²

Affiliation:

1. Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb, Zagreb, Croatia

2. School of Medicine, University of Zagreb, Zagreb, Croatia

3. Department of Gynaecology and Obstetrics, University Hospital Centre Zagre, Zagreb, Croatia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2021.1965335

Reference18 articles.

1. Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis

2. Center for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.

3. European Centre for Disease Prevention and Control [Internet]. Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update. 2018. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-carbapenem-resistant-enterobacteriaceae-first-update.

4. Current Promising Antibiotics and Future Approaches in Combating Carbapenemase-Producing Enterobacteriaceae

5. Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications;Expert Review of Anti-infective Therapy;2024-05-08